These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 4329751)

  • 1. [Physical chemical measurement of 140S particles of the foot-and-mouth disease virus].
    Fayet MT; Fargeaud D; Louisot P; Stellmann C; Roumiantzeff M
    Ann Inst Pasteur (Paris); 1971 Jul; 121(1):107-18. PubMed ID: 4329751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of a method for the quantitative determination of the immunizing antigen (140S) of the foot-and-mouth disease virus].
    Tekerlekov P; Vasileva L; Nikolova E; Veleva E
    Vet Med Nauki; 1985; 22(9):10-9. PubMed ID: 3002008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration and purification of foot-and-mouth disease (FMD) virus by polyethylenglycol (PEG).
    Kaaden OR; Dietzschold B; Matheka HD; Tokui T
    Arch Gesamte Virusforsch; 1971; 35(1):104-13. PubMed ID: 4331777
    [No Abstract]   [Full Text] [Related]  

  • 4. [Viral particle specific serums, used in complement fixation tests of foot-and-mouth disease virus].
    Roumiantzeff M; Fayet MT
    Ann Inst Pasteur (Paris); 1969 Jun; 116(6):833-51. PubMed ID: 4312138
    [No Abstract]   [Full Text] [Related]  

  • 5. An evalutation of some methods of assay of foot-and-mouth disease antigen for vaccines.
    Garland AJ; Mowat GN; Fletton B
    Dev Biol Stand; 1976; 35():323-32. PubMed ID: 198302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigenic properties of some strains of foot-and-mouth disease virus].
    Bazadze TsV
    Veterinariia; 1971 Aug; 9():34-5. PubMed ID: 4334672
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antigenic structures of the foot-and-mouth disease virus].
    Marchev N; Veleva E; Tsutsumanski V
    Vet Med Nauki; 1976; 13(9):100-4. PubMed ID: 67699
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of the antigenic structure of foot-and-mouth disease virus to the process of infection.
    Rowlands DJ; Sangar DV; Brown F
    J Gen Virol; 1971 Oct; 13(1):85-93. PubMed ID: 4331815
    [No Abstract]   [Full Text] [Related]  

  • 9. Three variants of foot-and-mouth disease virus type O: cell culture characteristics and antigenic differences.
    McVicar JW; Sutmoller P
    Am J Vet Res; 1972 Aug; 33(8):1627-33. PubMed ID: 4340052
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biological properties of virus strains, reproduced from infectious ribonucleic acid neurotropic foot-and-mouth disease virus mutants].
    Veckenstedt A; Hantschel H
    Arch Exp Veterinarmed; 1966 Jun; 20(3):581-7. PubMed ID: 4296901
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of the foot-and-mouth disease virus cultured on the BHK-21 cell line].
    Mitev G; Tekerlekov P
    Vet Med Nauki; 1973; 10(4):3-8. PubMed ID: 4370848
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogenic quality of foot-and-mouth disease virus.
    Strobbe R
    Dev Biol Stand; 1976; 35():311-21. PubMed ID: 198301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis by zonal centrifugation in a saccharose gradient of viral particles contained in a preparation of the foot-and-mouth disease virus].
    Fayet MT; Roumiantzeff M; Fargeaud D
    Rev Immunol Ther Antimicrob; 1969; 33(6):335-44. PubMed ID: 4315921
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and partial characterization of temperature-sensitive mutants of the SAT-1 strain of foot-and-mouth disease virus.
    Manor D; Goldblum N
    Isr J Med Sci; 1973 Feb; 9(2):145-9. PubMed ID: 4348741
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of gamma radiation on the infectivity, antigenicity and immunogenicity of the foot-and-mouth disease virus].
    Frescura T; Massa D; Cardaras P
    Boll Ist Sieroter Milan; 1972; 51(2):109-17. PubMed ID: 4345590
    [No Abstract]   [Full Text] [Related]  

  • 16. [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].
    Bauer K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):285-97. PubMed ID: 4318509
    [No Abstract]   [Full Text] [Related]  

  • 17. [Various physical and chemical properties of the 73s unit of the foot-and-mouth disease virus].
    Liebermann HT; Meissner J; Schulze P; Thalmann G
    Arch Exp Veterinarmed; 1976; 30(6):813-21. PubMed ID: 190967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the immunogenic potencies of purified inactivated foot-and-mouth disease virus particles with variable amounts of VP1 protein (author's transl)].
    Bernard S; Grosclaude J; Adamowicz P; Guerche J
    Ann Rech Vet; 1977; 8(1):79-94. PubMed ID: 195512
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for a group protein in foot-and-mouth disease virus particles.
    Talbot P; Rowlands DJ; Burroughs JN; Sangar DV; Brown F
    J Gen Virol; 1973 Jun; 19(3):369-80. PubMed ID: 4353213
    [No Abstract]   [Full Text] [Related]  

  • 20. [Some modern data on the antigenic makeup of the foot-and-mouth disease virus and their practical significance].
    Tekerlekov P
    Vet Med Nauki; 1976; 13(5):97-100. PubMed ID: 183347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.